HOME › DRUGS › LONCASTUXIMAB TESIRINE
ACTIVE SUBSTANCE / INN

LONCASTUXIMAB TESIRINE

Brand name(s): Zynlonta
EMA LISTED
AUTHORISED
Lymphoma, Large B-Cell, Diffuse;Lymphoma, B-Cell
ACTIVE SUBSTANCE
Loncastuximab Tesirine
REGULATORS
EMA
SPONSORS / MAH
Swedish Orphan Biovitrum AB
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ZynlontaSwedish Orphan Biovitrum ABAuthorised20/12/2022Lymphoma, Large B-Cell, Diffuse;Lymphoma, B-Cell

FULL INTELLIGENCE ON LONCASTUXIMAB TESIRINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →